Jennison Associates LLC Makes New Investment in CareTrust REIT, Inc. $CTRE

Key Points

• CareTrust REIT (CTRE) saw Jennison Associates LLC buy a new stake of 31,968 shares (≈$1.16M) in Q4, and overall institutional and hedge fund ownership now stands at about 87.77%.
• The company beat Q4 estimates with $0.50 EPS vs. $0.47 and $134.86M revenue, set FY2026 guidance of 1.90–1.95 EPS, and the Street consensus is a "Buy" with a $42.82 target and expected ~1.98 EPS for the year.
• CareTrust raised its quarterly dividend to $0.39 (from $0.34), an annualized $1.56 and ~4.0% yield, though the payout ratio is relatively high at 86.45%.

Jennison Associates LLC bought a new stake in shares of CareTrust REIT, Inc. (NYSE:CTRE - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 31,968 shares of the company's stock, valued at approximately $1,156,000.

A number of other institutional investors and hedge funds have also made changes to their positions in CTRE. Royal Bank of Canada lifted its holdings in shares of CareTrust REIT by 36.4% in the 1st quarter. Royal Bank of Canada now owns 179,501 shares of the company's stock worth $5,129,000 after purchasing an additional 47,936 shares during the last quarter. NewEdge Advisors LLC grew its stake in CareTrust REIT by 11.3% during the 1st quarter. NewEdge Advisors LLC now owns 33,628 shares of the company's stock worth $961,000 after buying an additional 3,408 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in CareTrust REIT by 134.2% in the second quarter. EverSource Wealth Advisors LLC now owns 1,124 shares of the company's stock worth $34,000 after buying an additional 644 shares during the period. First Trust Advisors LP increased its position in CareTrust REIT by 67.6% in the second quarter. First Trust Advisors LP now owns 245,154 shares of the company's stock worth $7,502,000 after buying an additional 98,850 shares during the period. Finally, Cerity Partners LLC lifted its stake in CareTrust REIT by 310.1% in the second quarter. Cerity Partners LLC now owns 36,640 shares of the company's stock valued at $1,121,000 after buying an additional 27,706 shares during the last quarter. 87.77% of the stock is currently owned by institutional investors and hedge funds.

CareTrust REIT Trading Up 0.0%

Shares of CTRE stock opened at $39.20 on Monday. CareTrust REIT, Inc. has a 1 year low of $27.27 and a 1 year high of $41.72. The firm has a market capitalization of $8.75 billion, a PE ratio of 25.29, a price-to-earnings-growth ratio of 2.62 and a beta of 0.77. The stock has a fifty day moving average of $39.02 and a two-hundred day moving average of $37.58. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.73 and a current ratio of 1.73.

CareTrust REIT (NYSE:CTRE - Get Free Report) last issued its quarterly earnings data on Thursday, February 12th. The company reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.47 by $0.03. The business had revenue of $134.86 million for the quarter. CareTrust REIT had a net margin of 67.28% and a return on equity of 8.98%. CareTrust REIT has set its FY 2026 guidance at 1.900-1.95 EPS. As a group, research analysts expect that CareTrust REIT, Inc. will post 1.98 EPS for the current year.

CareTrust REIT Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st were given a dividend of $0.39 per share. This is a positive change from CareTrust REIT's previous quarterly dividend of $0.34. The ex-dividend date was Tuesday, March 31st. This represents a $1.56 dividend on an annualized basis and a dividend yield of 4.0%. CareTrust REIT's payout ratio is presently 86.45%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. UBS Group boosted their price target on shares of CareTrust REIT from $44.00 to $48.00 and gave the company a "buy" rating in a report on Wednesday, February 18th. Wells Fargo & Company lifted their price objective on shares of CareTrust REIT from $41.00 to $42.00 and gave the company an "overweight" rating in a research report on Thursday, March 26th. Weiss Ratings raised shares of CareTrust REIT from a "buy (b+)" rating to a "buy (a-)" rating in a research note on Monday, January 26th. Cantor Fitzgerald upped their target price on shares of CareTrust REIT from $37.00 to $42.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 17th. Finally, Citizens Jmp started coverage on shares of CareTrust REIT in a research note on Thursday, January 22nd. They issued a "market outperform" rating and a $44.00 price target on the stock. Three investment analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $42.82.

CareTrust REIT Profile

CareTrust REIT, Inc is a real estate investment trust based in Deerfield Beach, Florida, specializing in the ownership, acquisition and management of net-leased healthcare properties. The company primarily focuses on seniors housing and post-acute care facilities, entering into long-term, triple-net lease agreements with leading operators in the skilled nursing, assisted living, memory care, inpatient rehabilitation and specialty hospital sectors. Through its portfolio, CareTrust REIT aims to provide investors with stable and predictable rental income while supporting the ongoing demand for quality healthcare real estate across the United States.

Since its initial public offering in September 2013, CareTrust REIT has pursued a disciplined acquisition strategy, targeting properties in primary and select secondary markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.